Cargando…

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India

Detalles Bibliográficos
Autores principales:	Kalaiselvan, Vivekanandan, Prasad, Thota, Bisht, Akanksha, Singh, Surinder, Singh, Gyanendra Nath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277146/ https://www.ncbi.nlm.nih.gov/pubmed/25488454

Ejemplares similares

Pharmacovigilance Programme of India: Recent developments and future perspectives
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

Adverse drug reactions due to ophthalmic drugs: Reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India
por: Agrawal, Vijit, et al.
Publicado: (2019)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
por: Thota, Prasad, et al.
Publicado: (2018)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
por: Kumar, Pramod, et al.
Publicado: (2017)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

System of adverse drug reactions reporting: What, where, how, and whom to report?
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2015)

An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme
por: Brashier, Dick B. S., et al.
Publicado: (2012)

“ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India
por: Prakash, Jai, et al.
Publicado: (2019)

Implementation of adverse event reporting for medical devices, India
por: Shukla, Shatrunajay, et al.
Publicado: (2020)

Veterinary pharmacovigilance in India: A need of hour
por: Kumar, Rishi, et al.
Publicado: (2017)

National blood donor vigilance programme: India
por: Bisht, Akanksha, et al.
Publicado: (2016)

Haemovigilance Programme of India: Analysis of transfusion reactions reported from January 2013 to April 2016 and key recommendations for blood safety
por: Bisht, Akanksha, et al.
Publicado: (2018)

Comment on: “Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts”
por: Magge, Arjun, et al.
Publicado: (2019)

Inclusion of Medical Colleges as Adverse Drug Reaction Monitoring Centers Under Pharmacovigilance Programme of India: Missing the Targets
por: Mahajan, Rajiv
Publicado: (2017)

Intraocular devices associated adverse events reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2020)

Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
por: Tandon, Vishal R., et al.
Publicado: (2015)

Hemovigilance Program–India
por: Bisht, Akanksha, et al.
Publicado: (2013)

Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
por: Sahu, Ram Kumar, et al.
Publicado: (2014)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
por: Bansod, Kishor A, et al.
Publicado: (2020)

Status of documentation grading and completeness score for Indian individual case safety reports
por: Vivekanandan, Kalaiselvan, et al.
Publicado: (2015)

An update on the Pharmacovigilance Programme of India
por: Lihite, Ratan J., et al.
Publicado: (2015)

Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database
por: Rastogi, Shruti, et al.
Publicado: (2022)

Cefixime-associated acute generalized exanthematous pustulosis: Rare cases in India
por: Kumar, Vipin, et al.
Publicado: (2018)

Adverse drug reaction profile of microtubule-damaging antineoplastic drugs: A focused pharmacovigilance study in India
por: Manohar, Hasitha Diana, et al.
Publicado: (2016)

Adverse event reporting tools and regulatory measures in India through outcome of pharmacovigilance programme of India
por: Prakash, Jai, et al.
Publicado: (2021)

National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017)
por: Bisht, Akanksha, et al.
Publicado: (2021)

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries
por: Yadav, Sachdev
Publicado: (2008)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance
por: Almandil, Noor B.
Publicado: (2016)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

Materiovigilance Programme of India: Current status and way forward
por: Saifuddin, P. K., et al.
Publicado: (2022)

Adverse drug reactions of nonsteroidal anti-inflammatory drugs
por: Wiwanitkit, Viroj
Publicado: (2011)

Adverse drug reaction of oseltamivir in pediatric patients
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Pattern of Adverse Drug Reactions to Anticancer Drugs: A Quantitative and Qualitative Analysis
por: Singh, Shruti, et al.
Publicado: (2017)

Antiretroviral adverse drug reactions pharmacovigilance in Harare City, Zimbabwe, 2017
por: Mugauri, Hamufare, et al.
Publicado: (2018)

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal
por: Shrestha, Sunil, et al.
Publicado: (2020)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data
por: Bellavite, Paolo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_75fkkqmb5ivk94n7i0jbkicrld